Pain Management Therapeutics Market - Global Industry Analysis

Pain Management Therapeutics Market By Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, and Other Indications), By Pain Type (Chronic and Acute), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 09-May-2022 Category: Healthcare Report Format : PDF Pages: 188 Report Code: ZMR-3373 Status : Published

The global pain management therapeutics market was valued over USD 70.96 billion in 2021 and is expected to increase to around USD 92.63 billion by 2028, with a CAGR of roughly 4.1 percent during the forecast period.

Description

Pain Management Therapeutics Market: Industry Prospective

The global pain management therapeutics market was valued over USD 70.96 billion in 2021 and is expected to increase to around USD 92.63 billion by 2028, with a CAGR of roughly 4.1 percent during the forecast period. The study examines the drivers, constraints, and challenges in the pain management therapeutics market, as well as their impact on demand throughout the forecast period. In addition, the report looks into potential opportunities in the market for pain management therapies.

Pain Management Therapeutics Market: Overview

Pain is a stressful emotional and sensory experience that occurs as a result of tissue injury or illness. Various conditions, such as multiple sclerosis, stomach ulcers, osteoarthritis, diabetic neuropathy, chronic arthritis, fibromyalgia, and cancer can also cause discomfort. The duration of the pain varies from short-term acute pain to long-term chronic pain. Acute pain might be modest and last a few seconds or weeks or months. Chronic pain can occur due to elderly joints and bone, nerve loss, or injury. Pain caused by tissue injury, nerve damage, or nociceptive pain is treated with a range of medicines. The majority of medications work by binding to protein targets on cell membranes and influencing the body's metabolic processes.

COVID-19 Impact:

During the initial years of the forecast period, the impact of COVID-19 is expected to have an influence on the pain management therapeutics market. The COVID-19 pandemic had put a strain on healthcare systems throughout the world, and as a result of government-imposed safety precautions, many clinics and pain services remained unavailable to the public. To reduce the threat of the virus spreading, most chronic pain clinics were declared non-urgent, and both outpatient and elective interventional operations were curtailed or canceled during the COVID-19 pandemic. However, demand for pain management medications is likely to increase in the second half of the forecast period, attributed to factors such as telemedicine and digital health which have emerged as suitable and effective means to provide critical medical services to patients with chronic pain.

Global Pain Management Therapeutics Market

Pain Management Therapeutics Market: Growth Drivers

Demand for pain management therapeutics is expected to rise as osteoarthritis, chronic diseases, and sports or accident injuries become more common.

According to research by the World Health Organization, rheumatoid arthritis affects 0.2 to 1% of the world's 7.9 billion people. Rheumatoid arthritis is an inflammatory disease that causes a variety of symptoms ranging from joint pain to immunological problems. This proportion is expected to rise dramatically in the near future. Furthermore, as a result of the prevalent sports culture, sports injuries are on the rise. According to WHO research, nearly 1 million people are killed or injured in road accidents each year, with the bulk of these deaths occurring in poor and developing nations. As a result, the number is expected to exceed 2 to 2.5 million as people's spending power rises and they become more affluent. Moreover, the rapid increase in the geriatric population also contributes to the expansion of the global pain management therapeutics market.

Pain Management Therapeutics Market: Restraints

The availability of alternate pain management systems may hamper the market growth.

The rise in issues about drug exploitation, as well as the expiration of patents on prescription pain medicine pharmaceuticals, are likely to impede the expansion of the pain management therapeutics market. In addition to that, the availability of replacements such as pain relief devices is expected to pose a barrier to the global pain management therapeutics market.

Pain Management Therapeutics Market: Opportunities

The launch of affordable and more effective drugs is expected to offer better growth opportunities to market growth.

The biggest cause of impairment in the world is pain, which is the most prevalent reason individuals seek medical attention. Chronic pain for instance is defined as pain that lasts longer than three months and affects more than one-third of the world's population. However, the advent in the pharmaceutical sector and increased research activities have boosted the market reach in emerging countries. New affordable drug therapeutics launched by Hisamitsu, GSK, Novartis, and AstraZeneca are further expected to drive market growth during the forecast period.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Pain Management Therapeutics Market: Challenges.

Market growth is expected to be slowed by a slew of opioid-related side effects.

Opioids are used to treat a variety of conditions including joint pain, back pain, stiffness, headaches, pain linked with cancer, and so on, but they also have a number of dangerous side effects such as nausea, minor concussions, breathing problems, and so on. Apart from that, one of the major drawbacks of these medicines is addiction. When people quit using potentially fatal substances, they get restless.

Pain Management Therapeutics Market: Segmentation

The global pain management therapeutics market is bifurcated based on drug class, indication, pain type, and region. Based on drug class, the market is split into anticonvulsants, NSAIDS, anesthetics, anti-migraine drugs, non-narcotics, antidepressant drugs, opioids, and analgesics. By indication, the market is categorized into chronic pain, neuropathic pain, arthritic pain, bone fracture, cancer pain, migraine, fibromyalgia, post-operative pain, acute appendicitis, muscle sprain/strain, and other indications. The pain type segment of the market is divided into acute and chronic.

Recent Developments

  • March 2021, the market has been introduced to "Salonpas," a pain-relieving gel for individuals suffering from arthritis (knee, ankles, hands, etc.). Hisamitsu America is the company that created the topical gel. The results of Hisamitsu America's newest clinical research were recently announced, supporting the argument for topical pain medications as first-line therapy for pain. Furthermore, it is a non-greasy gel that aids in the reduction of inflammation and gives relief from discomfort.
  • June 2020, GSK Consumer Healthcare has teamed up with Paula Abdul to promote the medicine "Voltaren Arthritis Pain Gel," which has been approved by the FDA for use as an over-the-counter drug.

Pain Management Therapeutics Market: Regional Landscape

North America to dominate the global market during the forecast period.

In 2021, North America had the biggest market share, accounting for 36 percent of the global pain management therapeutics market. The growth of this region is due to factors such as a healthy conversant population; excellent healthcare infrastructures such as top-tier hospitals, well-equipped laboratories with world-class centers in the United States and Canada; and a vast network of retail pharmacies in every state. Furthermore, the aging population is on the cusp of becoming quite powerful. Adults aged 65 and above, for example, might account for up to 24 percent of the population by 2060, up from around 16 percent now. However, Asia Pacific is anticipated to witness the fastest market growth throughout the projected period. This increase is due to the rise in the older population in various Asian countries, particularly Japan, India, and China, as well as an increase in chronic illnesses and joint disorders along with increased healthcare spending, and the refinement of the healthcare system.

Pain Management Therapeutics Market: Competitive Landscape

Key players operating in the global pain management therapeutics market include GlaxoSmithKline Plc., Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions, Inc., Pfizer, Inc., Purdue Pharma L.P., Merck & Co. Inc., Mylan NV., and Johnson & Johnson.

The global pain management therapeutics market is segmented as follows:

By Drug Class

  • NSAIDS
  • Anesthetics
  • Anticonvulsant
  • Anti-Migraine Drugs
  • Antidepressant Drugs
  • Opioids
  • Non-Narcotics
  • Analgesics

By Indication

  • Arthritic Pain
  • Neuropathic Pain
  • Cancer Pain
  • Chronic Pain
  • Post-Operative Pain
  • Migraine
  • Fibromyalgia
  • Bone Fracture
  • Muscle Sprain/Strain
  • Acute Appendicitis
  • Other

By Pain Type

  • Chronic
  • Acute

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Pain Management Therapeutics Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Pain Management Therapeutics Market : snapshot
  • Chapter 3. Global Pain Management Therapeutics Market - Industry Analysis
    • 3.1 Pain Management Therapeutics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Demand for pain management therapeutics is expected to rise as osteoarthritis
      • 3.2.2 chronic diseases
      • 3.2.3 and sports or accident injuries become more common.
    • 3.3 Market Restraints
      • 3.3.1. Availability of alternate pain management systems may hamper the market growth.
    • 3.4 Market Opportunities
      • 3.4.1. Launch of affordable and more effective drugs is expected to offer better growth opportunities to market growth.
    • 3.5 Market Challenges
      • 3.5.1. Market growth is expected to be slowed by a slew of opioid-related side effects.
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Drug Class
      • 3.7.2 Market attractiveness analysis By Indication
      • 3.7.3 Market attractiveness analysis By Pain Type
  • Chapter 4. Global Pain Management Therapeutics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Pain Management Therapeutics Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Pain Management Therapeutics Market - Drug Class Analysis
    • 5.1 Global Pain Management Therapeutics Market overview: By Drug Class
      • 5.1.1 Global Pain Management Therapeutics Market share, By Drug Class, 2021 and 2028
    • 5.2 NSAIDS
      • 5.2.1 Global Pain Management Therapeutics Market by NSAIDS, 2022 - 2028 (USD Billion)
    • 5.3 Anesthetics
      • 5.3.1 Global Pain Management Therapeutics Market by Anesthetics, 2022 - 2028 (USD Billion)
    • 5.4 Anticonvulsant
      • 5.4.1 Global Pain Management Therapeutics Market by Anticonvulsant, 2022 - 2028 (USD Billion)
    • 5.5 Anti-Migraine Drugs
      • 5.5.1 Global Pain Management Therapeutics Market by Anti-Migraine Drugs, 2022 - 2028 (USD Billion)
    • 5.6 Antidepressant Drugs
      • 5.6.1 Global Pain Management Therapeutics Market by Antidepressant Drugs, 2022 - 2028 (USD Billion)
    • 5.7 Opioids
      • 5.7.1 Global Pain Management Therapeutics Market by Opioids, 2022 - 2028 (USD Billion)
    • 5.8 Non-Narcotics
      • 5.8.1 Global Pain Management Therapeutics Market by Non-Narcotics, 2022 - 2028 (USD Billion)
    • 5.9 Analgesics
      • 5.9.1 Global Pain Management Therapeutics Market by Analgesics, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Pain Management Therapeutics Market - Indication Analysis
    • 6.1 Global Pain Management Therapeutics Market overview: By Indication
      • 6.1.1 Global Pain Management Therapeutics Market share, By Indication, 2021 and 2028
    • 6.2 Arthritic Pain
      • 6.2.1 Global Pain Management Therapeutics Market by Arthritic Pain, 2022 - 2028 (USD Billion)
    • 6.3 Neuropathic Pain
      • 6.3.1 Global Pain Management Therapeutics Market by Neuropathic Pain, 2022 - 2028 (USD Billion)
    • 6.4 Cancer Pain
      • 6.4.1 Global Pain Management Therapeutics Market by Cancer Pain, 2022 - 2028 (USD Billion)
    • 6.5 Chronic Pain
      • 6.5.1 Global Pain Management Therapeutics Market by Chronic Pain, 2022 - 2028 (USD Billion)
    • 6.6 Post-Operative Pain
      • 6.6.1 Global Pain Management Therapeutics Market by Post-Operative Pain, 2022 - 2028 (USD Billion)
    • 6.7 Migraine
      • 6.7.1 Global Pain Management Therapeutics Market by Migraine, 2022 - 2028 (USD Billion)
    • 6.8 Fibromyalgia
      • 6.8.1 Global Pain Management Therapeutics Market by Fibromyalgia, 2022 - 2028 (USD Billion)
    • 6.9 Bone Fracture
      • 6.9.1 Global Pain Management Therapeutics Market by Bone Fracture, 2022 - 2028 (USD Billion)
    • 6.10 Muscle Sprain/Strain
      • 6.10.1 Global Pain Management Therapeutics Market by Muscle Sprain/Strain, 2022 - 2028 (USD Billion)
    • 6.11 Acute Appendicitis
      • 6.11.1 Global Pain Management Therapeutics Market by Acute Appendicitis, 2022 - 2028 (USD Billion)
    • 6.12 Other
      • 6.12.1 Global Pain Management Therapeutics Market by Other, 2022 - 2028 (USD Billion)
  • Chapter 7. Global Pain Management Therapeutics Market - Pain Type Analysis
    • 7.1 Global Pain Management Therapeutics Market overview: By Pain Type
      • 7.1.1 Global Pain Management Therapeutics Market share, By Pain Type, 2021 and 2028
    • 7.2 Chronic
      • 7.2.1 Global Pain Management Therapeutics Market by Chronic, 2022 - 2028 (USD Billion)
    • 7.3 Acute
      • 7.3.1 Global Pain Management Therapeutics Market by Acute, 2022 - 2028 (USD Billion)
  • Chapter 8. Pain Management Therapeutics Market - Regional Analysis
    • 8.1 Global Pain Management Therapeutics Market Regional Overview
    • 8.2 Global Pain Management Therapeutics Market Share, by Region, 2021 & 2028 (USD Billion)
    • 8.3. North America
      • 8.3.1 North America Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
        • 8.3.1.1 North America Pain Management Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 North America Pain Management Therapeutics Market, by Drug Class, 2022 - 2028
      • 8.4.1 North America Pain Management Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 8.5 North America Pain Management Therapeutics Market, by Indication, 2022 - 2028
      • 8.5.1 North America Pain Management Therapeutics Market, by Indication, 2022 - 2028 (USD Billion)
    • 8.6 North America Pain Management Therapeutics Market, by Pain Type, 2022 - 2028
      • 8.6.1 North America Pain Management Therapeutics Market, by Pain Type, 2022 - 2028 (USD Billion)
    • 8.4. Europe
      • 8.4.2 Europe Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
        • 8.4.2.1 Europe Pain Management Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 Europe Pain Management Therapeutics Market, by Drug Class, 2022 - 2028
      • 8.4.1 Europe Pain Management Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 8.5 Europe Pain Management Therapeutics Market, by Indication, 2022 - 2028
      • 8.5.1 Europe Pain Management Therapeutics Market, by Indication, 2022 - 2028 (USD Billion)
    • 8.6 Europe Pain Management Therapeutics Market, by Pain Type, 2022 - 2028
      • 8.6.1 Europe Pain Management Therapeutics Market, by Pain Type, 2022 - 2028 (USD Billion)
    • 8.5. Asia Pacific
      • 8.5.3 Asia Pacific Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
        • 8.5.3.1 Asia Pacific Pain Management Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 Asia Pacific Pain Management Therapeutics Market, by Drug Class, 2022 - 2028
      • 8.4.1 Asia Pacific Pain Management Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 8.5 Asia Pacific Pain Management Therapeutics Market, by Indication, 2022 - 2028
      • 8.5.1 Asia Pacific Pain Management Therapeutics Market, by Indication, 2022 - 2028 (USD Billion)
    • 8.6 Asia Pacific Pain Management Therapeutics Market, by Pain Type, 2022 - 2028
      • 8.6.1 Asia Pacific Pain Management Therapeutics Market, by Pain Type, 2022 - 2028 (USD Billion)
    • 8.6. Latin America
      • 8.6.4 Latin America Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
        • 8.6.4.1 Latin America Pain Management Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 Latin America Pain Management Therapeutics Market, by Drug Class, 2022 - 2028
      • 8.4.1 Latin America Pain Management Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 8.5 Latin America Pain Management Therapeutics Market, by Indication, 2022 - 2028
      • 8.5.1 Latin America Pain Management Therapeutics Market, by Indication, 2022 - 2028 (USD Billion)
    • 8.6 Latin America Pain Management Therapeutics Market, by Pain Type, 2022 - 2028
      • 8.6.1 Latin America Pain Management Therapeutics Market, by Pain Type, 2022 - 2028 (USD Billion)
    • 8.7. The Middle-East and Africa
      • 8.7.5 The Middle-East and Africa Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
        • 8.7.5.1 The Middle-East and Africa Pain Management Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 The Middle-East and Africa Pain Management Therapeutics Market, by Drug Class, 2022 - 2028
      • 8.4.1 The Middle-East and Africa Pain Management Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 8.5 The Middle-East and Africa Pain Management Therapeutics Market, by Indication, 2022 - 2028
      • 8.5.1 The Middle-East and Africa Pain Management Therapeutics Market, by Indication, 2022 - 2028 (USD Billion)
    • 8.6 The Middle-East and Africa Pain Management Therapeutics Market, by Pain Type, 2022 - 2028
      • 8.6.1 The Middle-East and Africa Pain Management Therapeutics Market, by Pain Type, 2022 - 2028 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1 GlaxoSmithKline Plc.
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 Novartis AG
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Abbott Laboratories
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Eli Lilly & Company
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Endo Health Solutions Inc
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 Pfizer Inc
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 Purdue Pharma L.P.
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Merck & Co. Inc.
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Mylan NV.
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 Johnson & Johnson.
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Pain Management Therapeutics Market attractiveness, By Drug Class
  • 6. Global Pain Management Therapeutics Market attractiveness, By Indication
  • 7. Global Pain Management Therapeutics Market attractiveness, By Pain Type
  • 8. Global Pain Management Therapeutics Market share by Drug Class, 2022 and 2028 (USD Billion)
  • 9. Global Pain Management Therapeutics Market by NSAIDS, 2022 - 2028 (USD Billion)
  • 10. Global Pain Management Therapeutics Market by Anesthetics, 2022 - 2028 (USD Billion)
  • 11. Global Pain Management Therapeutics Market by Anticonvulsant, 2022 - 2028 (USD Billion)
  • 12. Global Pain Management Therapeutics Market by Anti-Migraine Drugs, 2022 - 2028 (USD Billion)
  • 13. Global Pain Management Therapeutics Market by Antidepressant Drugs, 2022 - 2028 (USD Billion)
  • 14. Global Pain Management Therapeutics Market by Opioids, 2022 - 2028 (USD Billion)
  • 15. Global Pain Management Therapeutics Market by Non-Narcotics, 2022 - 2028 (USD Billion)
  • 16. Global Pain Management Therapeutics Market by Analgesics, 2022 - 2028 (USD Billion)
  • 17. Global Pain Management Therapeutics Market share by Indication, 2022 and 2028 (USD Billion)
  • 18. Global Pain Management Therapeutics Market by Arthritic Pain, 2022 - 2028 (USD Billion)
  • 19. Global Pain Management Therapeutics Market by Neuropathic Pain, 2022 - 2028 (USD Billion)
  • 20. Global Pain Management Therapeutics Market by Cancer Pain, 2022 - 2028 (USD Billion)
  • 21. Global Pain Management Therapeutics Market by Chronic Pain, 2022 - 2028 (USD Billion)
  • 22. Global Pain Management Therapeutics Market by Post-Operative Pain, 2022 - 2028 (USD Billion)
  • 23. Global Pain Management Therapeutics Market by Migraine, 2022 - 2028 (USD Billion)
  • 24. Global Pain Management Therapeutics Market by Fibromyalgia, 2022 - 2028 (USD Billion)
  • 25. Global Pain Management Therapeutics Market by Bone Fracture, 2022 - 2028 (USD Billion)
  • 26. Global Pain Management Therapeutics Market by Muscle Sprain/Strain, 2022 - 2028 (USD Billion)
  • 27. Global Pain Management Therapeutics Market by Acute Appendicitis, 2022 - 2028 (USD Billion)
  • 28. Global Pain Management Therapeutics Market by Other, 2022 - 2028 (USD Billion)
  • 29. Global Pain Management Therapeutics Market share by Pain Type, 2022 and 2028 (USD Billion)
  • 30. Global Pain Management Therapeutics Market by Chronic, 2022 - 2028 (USD Billion)
  • 31. Global Pain Management Therapeutics Market by Acute, 2022 - 2028 (USD Billion)
  • 32. Global Pain Management Therapeutics Market share, by Region, 2022 and 2028
  • 33. North America Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
  • 34. Europe Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
  • 35. Asia Pacific Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
  • 36. Latin America Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)
  • 37. The Middle-East and Africa Pain Management Therapeutics Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Pain Management Therapeutics Market: Snapshot
  • 2. Drivers of the Pain Management Therapeutics Market: impact analysis
  • 3. North America Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 4. North America Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 5. North America Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 6. U.S. Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 7. U.S. Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 8. U.S. Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 9. Canada Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 10. Canada Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 11. Canada Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 12. Europe Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 13. Europe Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 14. Europe Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 15. Germany Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 16. Germany Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 17. Germany Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 18. France Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 19. France Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 20. France Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 21. U.K. Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 22. U.K. Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 23. U.K. Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 24. Italy Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 25. Italy Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 26. Italy Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 27. Spain Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 28. Spain Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 29. Spain Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 30. Rest of Europe Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 31. Rest of Europe Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 32. Rest of Europe Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 33. Asia Pacific Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 34. Asia Pacific Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 35. Asia Pacific Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 36. China Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 37. China Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 38. China Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 39. Japan Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 40. Japan Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 41. Japan Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 42. India Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 43. India Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 44. India Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 45. South Korea Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 46. South Korea Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 47. South Korea Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 48. South-East Asia Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 49. South-East Asia Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 50. South-East Asia Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 51. Rest of Asia Pacific Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 52. Rest of Asia Pacific Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 53. Rest of Asia Pacific Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 54. Latin America Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 55. Latin America Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 56. Latin America Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 57. Brazil Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 58. Brazil Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 59. Brazil Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 60. Mexico Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 61. Mexico Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 62. Mexico Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 63. Rest of Latin America Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 64. Rest of Latin America Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 65. Rest of Latin America Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 66. The Middle-East and Africa Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 67. The Middle-East and Africa Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 68. The Middle-East and Africa Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 69. GCC Countries Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 70. GCC Countries Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 71. GCC Countries Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 72. South Africa Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 73. South Africa Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 74. South Africa Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)
  • 75. Rest of Middle-East Africa Pain Management Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 76. Rest of Middle-East Africa Pain Management Therapeutics Market revenue, By Indication, 2022 - 2028 (USD Billion)
  • 77. Rest of Middle-East Africa Pain Management Therapeutics Market revenue, By Pain Type, 2022 - 2028 (USD Billion)

Methodology

Free Analysis

Pain is a multifarious medical condition, which not only affects the mental but also physical well-being of an individual. The intensity of pain caused due to tissue damage or trauma depends on person to person. The pain is categorized into two main categories, acute and chronic. Depending on the level or condition, the treatment differs. 

The increasing geriatric population, rising prevalence of chronic disease, and favorable regulatory scenario are the key factors contributing towards the growth of pain management therapeutics market globally. The advancement in new drug development for pain management and an untapped market in developing economies are expected to generate immense opportunity for the growth of the market over the forecast period.

Global Pain Management Therapeutics Market

The pain management therapeutics market is categorized into drug class, indication, distribution channel, and by geography. Based on drug class, the pain management therapeutics market is segmented into anesthetics, NSAIDs, anticonvulsants, antidepressants, anti-migraine agents, non-narcotic analgesics, and opioids. The opioids segment is further segmented into tramadol, oxycodone, hydrocodone, and others. By indications, the market for pain management therapeutics market is segmented as neuropathic pain, arthritic pain, post-operative pain, cancer pain, chronic back pain, fibromyalgia, and migraine. Based on the distribution channel, the global pain management therapeutics market is segmented into hospitals pharmacy, retail pharmacy, and online pharmacy. 

By geography, North America is anticipated to register the least growth rate, but in terms of revenue, it dominated the global pain management therapeutics market in 2017. Followed by North America, Europe accounted for the second highest revenue share in the global pain management therapeutics market and is expected to register significant CAGR over the forecast period. The increasing adoption of advanced pain management therapeutics and the ease of availability of sophisticated and well-established healthcare infrastructure are the chief factors contributing towards the high share of Europe and North America in the global pain management therapeutics market.

Some of the key players in the pain management therapeutics market are Pfizer Inc., Endo International Plc., Depomed, Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, AstraZeneca Plc., Novartis AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., and Abbott Laboratories. The growing demand for advanced drug development is increasing the competition among the key players operating in pain management therapeutics market, and this is expected to propel the growth of the pain management therapeutics market globally over the forecast period. 

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Demand for pain management therapeutics is expected to rise as osteoarthritis, chronic diseases, and sports or accident injuries become more common. According to research by the World Health Organization, rheumatoid arthritis affects 0.2 to 1% of the world's 7.9 billion people. Rheumatoid arthritis is an inflammatory disease that causes a variety of symptoms ranging from joint pain to immunological problems. This proportion is expected to rise dramatically in the near future. Furthermore, as a result of the prevalent support culture, sports injuries are on the rise.

According to the Zion Market Research report, the global pain management therapeutics market was worth about 70.96 (USD billion) in 2021 and is predicted to grow to around 92.63 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 4.1 percent.

In 2021, North America had the biggest market share, accounting for 36 percent of the total market. The growth of this region is due to factors such as a healthy conversant population, excellent healthcare infrastructures such as top-tier hospitals, well-equipped laboratories with world-class centers in the United States and Canada, and a vast network of retail pharmacies and pharmacies in every state

Key players operating in the global pain management therapeutics market include GlaxoSmithKline Plc., Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions, Inc., Pfizer, Inc., Purdue Pharma L.P., Merck & Co. Inc., Mylan NV., and Johnson & Johnson.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed